about
[The role of Helicobacter pylori infection in children with chronic immune thrombocytopenic purpura].Intestinal alkaline phosphatase in the colonic mucosa of children with inflammatory bowel disease.Characteristics of allergic colitis in breast-fed infants in the absence of cow's milk allergyAltered mucosal expression of microRNAs in pediatric patients with inflammatory bowel disease.Role of Altered Expression of miR-146a, miR-155, and miR-122 in Pediatric Patients with Inflammatory Bowel Disease.Baseline Characteristics and Disease Phenotype in Inflammatory Bowel Disease.Increased expression of serum- and glucocorticoid-regulated kinase-1 in the duodenal mucosa of children with coeliac disease.Short-term omeprazole treatment does not influence biochemical parameters of bone turnover in children.Cytokines and adhesion molecules in duodenal mucosa of children with delayed-type food allergy.Incidence, Paris classification, and follow-up in a nationwide incident cohort of pediatric patients with inflammatory bowel disease.Low mannose-binding lectin (MBL) is associated with paediatric inflammatory bowel diseases and ileal involvement in patients with Crohn disease.[Milestones in understanding the pathogenesis of immunmediated intestinal disorders. Evolution of their diagnosis and therapy].Slight decrease in bone mineralization in cow milk-sensitive children.Genetic polymorphisms of CD14, toll-like receptor 4, and caspase-recruitment domain 15 are not associated with necrotizing enterocolitis in very low birth weight infants.Autoregressive cross-lagged models of IMPACT-III and Pediatric Crohn's Disease Activity Indexes during one year infliximab therapy in pediatric patients with Crohn's disease.Serum immunoglobulin E, IgA, and IgG antibodies to different cow's milk proteins in children with cow's milk allergy: association with prognosis and clinical manifestations.Seasonal variability of vitamin D and bone metabolism in infliximab-treated paediatric Crohn's disease.Peroxisome proliferator-activated receptor-γ and thymic stromal lymphopoietin are involved in the pathophysiology of childhood coeliac disease.Pancreatic autoantibodies and autoantibodies against goblet cells in pediatric patients with inflammatory bowel disease.Decreased mucosal expression of intestinal alkaline phosphatase in children with coeliac disease.The role of intestinal alkaline phosphatase in pediatric inflammatory bowel and celiac diseasesImmune Phenotype of Children with Newly Diagnosed and Gluten-Free Diet-Treated Celiac DiseaseIncreased Heat Shock Protein 72 Expression in Celiac DiseaseIncreased expression of Toll-like receptor (TLR) 2 and TLR4 in the colonic mucosa of children with inflammatory bowel diseaseIncreased Mucosal Expression of Toll-like Receptor (TLR)2 and TLR4 in Coeliac DiseaseNatural killer cell activity in celiac disease in children on a gluten-free diet and after gluten challengeIncreased frequency of IgM antibodies to cow's milk proteins in Hungarian children with newly diagnosed insulin-dependent diabetes mellitusDecreased Na+/K+ pump activity in the erythrocytes of children with treated celiac diseaseIncreased expression of intercellular adhesion molecule-1 and mucosal adhesion molecule alpha4beta7 integrin in small intestinal mucosa of adult patients with food allergyHigher serum eosinophil cationic protein levels in children with cow's milk allergyJejuna of patients with insulin-dependent diabetes mellitus (IDDM) show signs of immune activationFrequency of coeliac disease in Hungarian children with type 1 diabetes mellitus[Chronic intestinal pseudoobstruction due to visceral myopathy][Incidence of thyroid autoimmunity in children with type 1 diabetes mellitus][Vena portae obstruction as a cause of portal hypertension in a child with Turner syndrome]Frequencies of genetic polymorphisms of TLR4 and CD14 and of HLA-DQ genotypes in children with celiac disease, type 1 diabetes mellitus, or both[Analysis of infliximab treated pediatric patients with Crohn disease in Hungary]Mucosal expression of claudins 2, 3 and 4 in proximal and distal part of duodenum in children with coeliac diseaseIncreased expression of hypoxia-inducible factor 1alpha in coeliac disease[Adalimumab treatment in infliximab-resistant pediatric patient with Crohn's disease]
P50
Q33384071-D6AC322C-2D56-4CF4-834F-F501EB7610F6Q36082190-726F47AF-6710-4F9F-9B61-21F0F15DA704Q36975057-A3663123-5733-4C93-970A-8BBB1A0E9E67Q39026427-CA5AD898-6F8D-4E78-ABB3-D912F7358755Q40122523-8EA76FEC-CBEB-4C72-8D8E-F58DC1405527Q40717430-9E5EBF09-2961-4A9E-8143-CA6099DD0A6DQ43228562-939BB4DA-BA36-49AB-A417-101A0F0FE3A5Q44117823-69933B6F-5E4A-4DC7-9949-5EE288721F13Q44491726-4700F968-5821-4198-9A04-D7A20893F13CQ45133313-08E33BE7-73E8-4B06-AAEC-FB3C69D0A3ADQ45170131-74DDE17C-D29B-4C56-9797-235A15018601Q46119852-3A4E2AB7-79FF-4B54-9F5E-073760001585Q46287643-B46B2F72-00FF-4ABF-889D-B8F0B2D0A475Q47355576-A14B5EEC-5059-44AF-AA5D-F7DC6C5AC78DQ48095772-7B167FE3-C28C-4EF9-8D0A-DCCDD2D14F33Q51700453-0F2B45B6-F800-4D64-BEEC-71E6310C7485Q53467812-F80E959E-6B89-4B61-82EB-A4F3334AC076Q54192856-ADA870C4-9BC6-48BE-B5D1-FF18BAE68BDAQ54316602-F0D8D870-96DF-44B2-8111-FF511377DF36Q54328204-A34AC137-3D16-4EB6-BE5A-D42983BD619EQ58763323-37E0B57A-B6BD-43B0-88AD-1E3A05F7E629Q58763330-C183483B-1CBE-4FC8-96A6-9B9DCF3C4B7CQ58763344-4021B4FC-5FF9-4011-9E8D-7F6F4D6201B8Q58763371-DE2FE620-4018-424D-88C5-7DFA9899A051Q58763377-DA228A2D-9F7A-434C-83D9-792DDDDBA22BQ68250689-DBC92B01-0C53-4F4D-BFA2-82618E661ADCQ71725953-959BFA35-8C9F-4907-A31B-27824A9E5BE8Q73803640-B71AC781-0087-49A3-8B48-303653EB1A2AQ73893279-E06EEDFA-F522-4CA3-9BBD-0C40E99B1642Q73986955-9CD4E3E3-B9C7-42C6-9FE1-5E403F4AD872Q77344136-094A8DCB-179B-41DE-9A48-6F48F484EE38Q78675447-6A9844B1-6F21-420E-ABAB-6859E43E2404Q80567863-E4961664-C5BF-4181-ABA9-3F450589EBF0Q80751091-E038A3E8-3595-4D01-83BC-EB20C10B43D8Q81357349-D192BE94-3686-4179-9BB3-94D9A86E7655Q81830511-9184248B-0C56-402D-BDA0-FC623A993B79Q82554177-423C56CF-54FC-4ACE-AFCF-E42C69B57FB3Q82836848-C4E2BD1A-9F10-4C2E-AB15-93BB0C5BA16EQ84190136-107A74A1-6E1B-4EA3-B27C-8EB8DA0BCD10Q84595666-3B9699C2-E95D-4F74-93AC-30CC87E4BDEC
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Andras Arato
@ast
Andras Arato
@en
Andras Arato
@es
Andras Arato
@nl
type
label
Andras Arato
@ast
Andras Arato
@en
Andras Arato
@es
Andras Arato
@nl
prefLabel
Andras Arato
@ast
Andras Arato
@en
Andras Arato
@es
Andras Arato
@nl
P106
P1153
7004262422
P31
P496
0000-0002-7980-6327